Zoetis reported $443.95M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
AbbVie USD 18M 0 Dec/2024
Align Technology USD 72.48M 572K Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Charles River Laboratories USD 49.21M 48.7M Jun/2025
Dentsply International USD 199.3M 196.3M Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Henry Schein USD 121.9M 120.9M Jun/2025
Idexx Laboratories USD 80.42M 63.77M Jun/2025
Illumina USD 154M 152M Jun/2025
IQVIA Holdings USD 170M 167.42M Jun/2025
J&J USD 3.12B 0 Mar/2025
Laboratory Of America USD 82.9M 75.3M Jun/2025
Merck USD 1.79B 0 Mar/2025
Neogen USD 217.04M 182.32M May/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 6.56B Jun/2025
Pfizer USD 5.68B 5.2B Jun/2025
Quest Diagnostics USD 112M 110M Jun/2025
Sanofi 1.22B 36.5M Jun/2025
Sanofi 1.22B 36.5M Jun/2025
Zoetis USD 443.95M 438.95M Jun/2025